View Author
patient platelet transfusion group leukemia study evi 1 myeloid leukemia treatment expression g-csf abnormality blood mll –ptd survival cycle table count myeloid analysis cytogenetic evi 1 expression cytarabine karyotype 1-evi number effect factor reference remission mds 1-evi square meter aml patients value sample prognostic high-dose difference chemotherapy t-cell platelet transfusion event result death platelet transfusions therapy chromosome autosomal mds 1-evi expression granulocyte colony-stimulating factor increment response marrow cytogenetic abnormalities high-dose cytarabine induction center monosomy plasma period 109/ transcript relapse outcome autosomal monosomies university platelet support square meter bone marrow leukemic cells product percent erasmu paediatric society monosomie 24- promyelocytic leukemia rt-pcr
9 Most Recent Publications
|
Cytarabine dose for acute myeloid leukemia
(Article)
Löwenberg, B. Pabst, T. Greef, G.E. de Verdonck, L.F. Schaafsma, M.R. Gregor, M. Theobald, M. Schanz, U. Maertens, J. Ossenkoppele, G.J. Vellenga, E. Putten, W. van Schouten, H.C. Graux, C. Ferrant, A. Sonneveld, P. Biemond, B.J. Gratwohl, A. |
2011-03-17
|
|
Clinical effectiveness of leucoreduced, pooled donor platelet concentrates, stored in plasma or additive solution with and without pathogen reduction
(Article)
Kerkhoffs, J.-L.H. Putten, W.L.J. van Brand, A. Rhenen, D.J. van Novotny, V.M.J. Boekhorst, P.A.W. te Schipperus, M.R. Zwaginga, J.J. Pampus, L.C.M. Greef, G.E. de Luten, M. Huijgens, P.C. |
2010-07-01
|
|
Low frequency of MLL-partial tandem duplications in paediatric acute myeloid leukaemia using MLPA as a novel DNA screenings technique
(Article)
Balgobind, B.V. Hollink, I.H.I.M. Zwaan, C.M. Heuvel-Eibrink, M.M. van den Reinhardt, D. Wering, E.R. van Graaf, S.S.N. de Baruchel, A. Stary, J. Beverloo, H.B. Greef, G.E. de Pieters, R. |
2010-07-01
|
|
Monosomal karyotype in acute myeloid leukemia: A better indicator of poor prognosis than a complex karyotype
(Article)
Breems, D.A. Putten, W.L.J. van Löwenberg, B. Greef, G.E. de Zelderen-Bhola, S.L. van Gerssen-Schoorl, K.B.J. Mellink, C.H.M. Nieuwint, A. Jotterand, M. Hagemeijer, A. Beverloo, H.B. |
2008-10-10
|
|
Kinetic analysis reveals potency of CD4+ CD25bright+ regulatory T-cells in kidney transplant patients
(Article)
Velthuis, J.H.L. Hesselink, D.A. Hendrikx, T.K. Mast, B.J. van der Klepper, M. Greef, G.E. de Baan, C.C. Weimar, W. |
2007-11-01
|
|
Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial
(Article)
Rhenen, D.J. van Marblie, S. Corash, L. Flament, J. Ljungman, P. Kluter, H. Vermeij, H. Mayaudon, V. Lin, L. Kappers-Klunne, M.C. Buchholz, D. Greef, G.E. de Laforet, M. Davis, K. Conlan, M. Lioure, B. Gulliksson, H. Cazenave, J.P. Metzel, P. Pamphilon, D. |
2003-03-15
|
|
High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patients
(Article)
Beverloo, H.B. Sonneveld, P. Poel-van de Luytgaarde, S.C.P.A.M. van der Hack, R. Slater, R. Greef, G.E. de Khosrovani, S. Smit, E.M.E. Verhoef, G. Ossenkoppele, G.J. Delwel, H.R. Verdonck, L.F. Erpelinck, C.A.J. Putten, W.L.J. van Valk, P.J.M. Löwenberg, B. |
2003-01-01
|
|
Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia
(Article)
Löwenberg, B. Kovacsovics, T. Daenen, S.M.G.J. Ferrant, A. Gratwohl, A. Greef, G.E. de Putten, W.L.J. van Theobald, M. Gmur, J. Boogaerts, M. Verdonck, L.F. Sonneveld, P. Fey, M.F. Huijgens, P. |
2003-01-01
|
|
Complete remission of t(11;17) positive acute promyelocytic leukemia induced by all-trans retinoic acid and granulocyte colony-stimulating factor
(Article)
Jansen, J.H. Breems-de Ridder, M.C. Smit, E.M.E. Geertsma, W.M. Erpelinck, C.A.J. Lom, K. van Slater, R. Reijden, B.A. van der Greef, G.E. de Sonneveld, P. Löwenberg, B. |
1999-01-01
|
